Finally, the molecular mechanism by which CXCL10 and CXCL11 are involved in immune cell infiltration in pancreatic cancer was analyzed, and these results are anticipated to facilitate pancreatic cancer immunotherapy. The gene discussed is CXCL11; the disease is familial pancreatic carcinoma.